Naomi comes from a decade at the intersection of consumer health, behavioral science, and applied biotech. She spent five years as VP of Product at a longevity-focused biotech company, building products meant to survive contact with real patient behavior, not just controlled environments. Before that, she was an EIR at a top-tier seed fund, sitting close enough to early-stage chaos to see what actually holds up past pitch decks.

Her edge is clinical in the literal sense — she understands what drives sustained human behavior change in healthcare systems, not just what looks compelling in a demo or trial. That lens filters heavily for adoption over aesthetics, outcomes over intent, and real-world compliance over theoretical efficacy.

She holds a PhD in Cognitive Neuroscience from Stanford, grounding her intuition in how people actually perceive, decide, and stick with interventions when life gets noisy.